New Zealand markets close in 2 hours 10 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
90.94-0.58 (-0.63%)
At close: 04:00PM EDT
90.88 -0.06 (-0.07%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
201,325,000
176,954,000
140,800,000
126,946,000
122,021,000
Cost of revenue
31,500,000
28,448,000
23,658,000
20,932,000
20,088,000
Gross profit
169,825,000
148,506,000
117,142,000
106,014,000
101,933,000
Operating expenses
Research development
27,573,000
24,047,000
17,772,000
15,462,000
14,220,000
Selling general and administrative
56,597,000
50,684,000
41,058,000
36,886,000
35,830,000
Total operating expenses
83,659,000
73,697,000
58,498,000
51,888,000
49,450,000
Operating income or loss
86,166,000
74,809,000
58,644,000
54,126,000
52,483,000
Interest expense
-3,837,000
378,000
2,451,000
390,000
220,000
Total other income/expenses net
-
-5,427,000
616,000
-793,000
-3,494,000
Income before tax
83,339,000
69,062,000
59,080,000
53,130,000
48,553,000
Income tax expense
16,100,000
13,537,000
11,323,000
10,992,000
9,602,000
Income from continuing operations
67,239,000
55,525,000
47,757,000
42,138,000
38,951,000
Net income
67,239,000
55,525,000
47,757,000
42,138,000
38,951,000
Net income available to common shareholders
67,239,000
55,525,000
47,757,000
42,138,000
38,951,000
Basic EPS
-
24.51
20.79
18.05
16.41
Diluted EPS
-
24.44
20.74
18.01
16.38
Basic average shares
-
2,265,300
2,296,600
2,333,900
2,374,299
Diluted average shares
-
2,272,300
2,303,100
2,340,000
2,378,658